Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Allotopic expression of ND6 restores vision in a mitochondrial disease model
Cheng Ai, Huiying Li, Jing Wu, Tianwei Zhou, Jing Wang, Shao-Hui Pan, Jun Yu, Douglas C. Wallace, Min-Xin Guan
Cheng Ai, Huiying Li, Jing Wu, Tianwei Zhou, Jing Wang, Shao-Hui Pan, Jun Yu, Douglas C. Wallace, Min-Xin Guan
View: Text | PDF
Research Article Genetics Ophthalmology

Allotopic expression of ND6 restores vision in a mitochondrial disease model

  • Text
  • PDF
Abstract

Mutations in mitochondrial DNA (mtDNA) cause various mitochondrial diseases that are currently incurable. Allotopic expression of nucleus-recoded mitochondrial genes represents a promising therapeutic strategy, given its demonstrated capacity to restore mitochondrial function in human cell models harboring mtDNA mutations. However, the in vivo evaluation of allotopic gene therapy has been hindered by optimization challenges and the lack of appropriate animal models. Here, we overcome these limitations by utilizing an optimized AAV2-ND6 construct with codon optimization and mitochondrial targeting sequence in a mouse model bearing the homoplasmic ND6P25L mutation, which recapitulates Leber hereditary optic neuropathy (LHON). High-dose administration of the AAV2-ND6 construct resulted in robust, sustained expression within the retina and optic nerve without apparent systemic toxicity. Strikingly, we compared the therapeutic efficacy in mutant mice at different ages and presymptomatic intervention with AAV2-ND6 effectively attenuated disease progression, mitigated retinal cellular deficiencies and optic nerve damage, and restored visual function in ND6P25L mice. Mechanistically, allotopic ND6 expression markedly rescued the mitochondrial dysfunction, corrected dysregulated retinol metabolism and phototransduction pathways, and suppressed apoptotic processes in the mutant retina. Our study validates the safety and therapeutic potential of allotopic expression in vivo and provides critical mechanistic insights into its role in treating LHON and other mitochondrial diseases.

Authors

Cheng Ai, Huiying Li, Jing Wu, Tianwei Zhou, Jing Wang, Shao-Hui Pan, Jun Yu, Douglas C. Wallace, Min-Xin Guan

×

Figure 5

Transcriptome analysis of mouse retinas.

Options: View larger image (or click on image) Download as PowerPoint
Transcriptome analysis of mouse retinas.
(A) Bar plot showing KEGG pathw...
(A) Bar plot showing KEGG pathway enrichment for downregulated genes in ND6 mice, as compared with WT mice. The x axis represented the number of differentially expressed genes and the color indicates q value. KEGG, Kyoto Encyclopedia of Genes and Genomes. (B) Bar plot showing KEGG pathway enrichment for upregulated genes in ND6+AAV mice, as compared with ND6 mice. The x axis represented the number of differentially expressed genes and the color indicates q value. (A and B) Red asterisks indicate the dysregulated retinol metabolism pathway. (C) Representative GSEA pathway that was significantly downregulated in ND6 mice, as compared with WT mice. GSEA, gene set enrichment analysis; NES, normalized enrichment score. (D) Representative GSEA pathways that were significantly upregulated in ND6+AAV mice, as compared with ND6 mice. (E) Heatmap displaying expression of genes involved in retinol metabolism by mean-centered log2 TPM in various mice. TPM, transcripts per kilobase million. (F) Western blot analysis of proteins involved in retinol metabolism (RARB, RDH5, RDH12, CRPBP2, STRA6, and RPE65). GAPDH was used as a loading control. (G) Western blot analysis of proteins involved in retinol metabolism (PDE6B, GNGT1, NMDAR1, RHO, and PRKCQ). GAPDH was used as a loading control. (H) Heatmap displaying expression of genes involved in phototransduction by mean-centered log2 TPM in various mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts